These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 16834561)

  • 1. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The silent treatment: siRNAs as small molecule drugs.
    Dykxhoorn DM; Palliser D; Lieberman J
    Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.
    Chakraborty C
    Curr Drug Targets; 2007 Mar; 8(3):469-82. PubMed ID: 17348839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene silencing by small interfering RNA-based knock-down technology.
    Zhang J; Hua ZC
    Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi: gene-silencing in therapeutic intervention.
    Shuey DJ; McCallus DE; Giordano T
    Drug Discov Today; 2002 Oct; 7(20):1040-6. PubMed ID: 12546893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference--a silent but an efficient therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SiRNA technology, the gene therapy of the future?].
    Rácz Z; Hamar P
    Orv Hetil; 2008 Jan; 149(4):153-9. PubMed ID: 18201957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small RNA: can RNA interference be exploited for therapy?
    Wall NR; Shi Y
    Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of siRNAs targeting the spacer sequence of plant RNAi vectors on the specificity and efficiency of RNAi.
    Nishimura K; Hirai S; Kodama H
    J Biosci Bioeng; 2009 Nov; 108(5):435-7. PubMed ID: 19804870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
    Mehrotra N; Tripathi RM
    IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.